Venmax Drugs and Pharmaceuticals Ltd — Board Meeting, 01-05-2025: Board Meeting

Venmax Drugs and Pharmaceuticals Limited has announced a board meeting on May 9, 2025, to approve the audited standalone financial results for the year and quarter ended March 31, 2025. The trading window for designated persons remains closed from April 1, 2025, until 48 hours after the results approval, reflecting ongoing compliance with insider trading norms. This update signals upcoming financial disclosures important for assessing the company’s annual performance.